StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$8.56−0.64 (-6.96%)

Close on Nov 18, 2026Market cap $764.38MP/E –Yield –

Syndax Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Syndax Pharmaceuticals's revenue for the twelve months ending Sep 30, 2026 was $289.68M, up 159.7% year over year. For fiscal 2025 it was $172.35M, up 627.8% from the year before. Over ten years it grew 75.4% a year on average. The highest annual figure on record is $172.35M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$172.35M+627.8%
FY2024Dec 31, 2024$23.68M–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$139.71M+9109.6%
FY2020Dec 31, 2020$1.52M0.0%
FY2019Dec 31, 2019$1.52M0.0%
FY2018Dec 31, 2018$1.52M-28.0%
FY2017Dec 31, 2017$2.11M+72.8%
FY2016Dec 31, 2016$1.22M+94.6%
FY2015Dec 31, 2015$627.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$83.30M+81.6%
Q2 FY2026Jun 30, 2026$72.79M+91.8%
Q1 FY2026Mar 31, 2026$64.86M+223.6%
Q4 FY2025Dec 31, 2025$68.73M+794.9%
Q3 FY2025Sep 30, 2025$45.87M+267.0%
Q2 FY2025Jun 30, 2025$37.96M+984.5%
Q1 FY2025Mar 31, 2025$20.04M–
Q4 FY2024Dec 31, 2024$7.68M–
Q3 FY2024Sep 30, 2024$12.50M–
Q2 FY2024Jun 30, 2024$3.50M–
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q4 FY2021Dec 31, 2021$126.58M+33209.5%
Q3 FY2021Sep 30, 2021$12.38M+3165.2%
Q2 FY2021Jun 30, 2021$379.00K0.0%
Q1 FY2021Mar 31, 2021$379.00K0.0%
Q4 FY2020Dec 31, 2020$380.00K0.0%
Q3 FY2020Sep 30, 2020$379.00K0.0%
Q2 FY2020Jun 30, 2020$379.00K0.0%
Q1 FY2020Mar 31, 2020$379.00K0.0%
Q4 FY2019Dec 31, 2019$380.00K0.0%
Q3 FY2019Sep 30, 2019$379.00K0.0%
Q2 FY2019Jun 30, 2019$379.00K0.0%
Q1 FY2019Mar 31, 2019$379.00K0.0%
Q4 FY2018Dec 31, 2018$380.00K-68.1%
Q3 FY2018Sep 30, 2018$379.00K+24.3%
Q2 FY2018Jun 30, 2018$379.00K+24.3%
Q1 FY2018Mar 31, 2018$379.00K+24.3%
Q4 FY2017Dec 31, 2017$1.19M+291.1%
Q3 FY2017Sep 30, 2017$305.00K–
Q2 FY2017Jun 30, 2017$305.00K–
Q1 FY2017Mar 31, 2017$305.00K–
Q4 FY2016Dec 31, 2016$305.00K–

More Syndax Pharmaceuticals figures

See a number that looks wrong?